Alcohol-free red wine enhances plasma antioxidant capacity in humans.

Moderate wine consumption is reputed to exert a protective effect against coronary heart disease (CHD). The nature of the protective compounds is unclear and the mechanisms are incompletely understood. We studied whether the nonalcoholic component of wine increases plasma antioxidant capacity measured as total radical-trapping antioxidant parameter (TRAP), and whether such an effect is associated with the presence of phenolic compounds in plasma. The TRAP and plasma levels of phenolic compounds were measured in 10 healthy subjects after the ingestion of 113 mL of tap water (control) and alcohol-free red and white wine at 1-wk intervals. Both alcohol-free wines possessed an in vitro dose-dependent peroxyl-radical activity, but red wine, with a polyphenol concentration of 363 +/- 48.0 mg/L quercetin equivalent (QE), was 20 times more active (40.0 +/- 0.1 mmol/L) than white wine (1.9 +/- 0.1 mmol/L), which has a polyphenol concentration of 31 +/- 1 mg QE/L. The ingestion of alcohol-free red wine caused significant increases in plasma TRAP values and polyphenol concentrations 50 min after ingestion. Alcohol-free white wine and water had no effects on either of the plasma values. The parallel and prompt increase of antioxidant status and of circulating levels of polyphenols in fasting subjects after bolus ingestion of a moderate amount of alcohol-free red wine suggests that polyphenols are absorbed in the upper gastrointestinal tract and might be directly involved in the in vivo antioxidant defenses.

[1]  T. Koivula,et al.  Relationship of alcohol consumption to changes in HDL‐subfractions , 1993, European journal of clinical investigation.

[2]  L. Videla,et al.  Alcohol ingestion, liver glutathione and lipoperoxidation: metabolic interrelations and pathological implications. , 1982, Life sciences.

[3]  A. Ferro-Luzzi,et al.  Application of a new high-performance liquid chromatographic method for measuring selected polyphenols in human plasma. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[4]  A. Ferro-Luzzi,et al.  Beta-carotene serum response in young and elderly females. , 1989, European Journal of Clinical Nutrition.

[5]  C. Lieber,et al.  Enhanced stimulatory effect of high density lipoproteins (HDL) and other agonists on vascular prostacyclin production in rats fed alcohol-containing diets. , 1989, Biochemical pharmacology.

[6]  M. Katan,et al.  Red wine consumption does not affect oxidizability of low-density lipoproteins in volunteers. , 1996, The American journal of clinical nutrition.

[7]  A. Lavy,et al.  Effect of dietary supplementation of red or white wine on human blood chemistry, hematology and coagulation: favorable effect of red wine on plasma high-density lipoprotein. , 1994, Annals of nutrition & metabolism.

[8]  W. Willett,et al.  Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. , 1993, The New England journal of medicine.

[9]  A. Waterhouse,et al.  Principal Phenolic Phytochemicals in Selected California Wines and Their Antioxidant Activity in Inhibiting Oxidation of Human Low-Density Lipoproteins , 1995 .

[10]  W. Willett,et al.  Mediterranean diet pyramid: a cultural model for healthy eating. , 1995, The American journal of clinical nutrition.

[11]  A. Ferro-Luzzi,et al.  In vivo antioxidant effect of green and black tea in man. , 1996, European journal of clinical nutrition.

[12]  A. Kimball,et al.  Coronary heart disease mortality and alcohol consumption in Framingham. , 1986, American journal of epidemiology.

[13]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.

[14]  M. Taskinen,et al.  Alcohol-induced changes in serum lipoproteins and in their metabolism. , 1987, American heart journal.

[15]  G. Lescoat,et al.  Role of flavonoids and iron chelation in antioxidant action. , 1994, Methods in enzymology.

[16]  E. Rimm,et al.  Prospective study of alcohol consumption and risk of coronary disease in men , 1991, The Lancet.

[17]  W. E. Hillis,et al.  The phenolic constituents of Prunus domestica. I.—The quantitative analysis of phenolic constituents , 1959 .

[18]  T. Whitehead,et al.  Effect of red wine ingestion on the antioxidant capacity of serum. , 1995, Clinical chemistry.

[19]  J. Folts,et al.  Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. , 1995, Circulation.

[20]  R. D. Situnayake,et al.  Lipid peroxidation and hepatic antioxidants in alcoholic liver disease. , 1990, Gut.

[21]  G. Ellman TISSUE SULPHYDRYL GROUPS , 1959 .

[22]  A. Lavy,et al.  Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. , 1995, The American journal of clinical nutrition.

[23]  P. Hollman,et al.  Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. , 1995, The American journal of clinical nutrition.

[24]  K. Kondo,et al.  Inhibition of oxidation of low-density lipoprotein with red wine , 1994, The Lancet.

[25]  A. Broillet,et al.  The metabolism and excretion of (+)-[14C]cyanidanol-3 in man following oral administration. , 1983, Xenobiotica; the fate of foreign compounds in biological systems.

[26]  W. Willett,et al.  A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. , 1988, The New England journal of medicine.

[27]  A. Ferro-Luzzi,et al.  A fluorescence-based method for measuring total plasma antioxidant capability. , 1995, Free radical biology & medicine.

[28]  P. Schnohr,et al.  Influence of sex, age, body mass index, and smoking on alcohol intake and mortality , 1994, BMJ.

[29]  B. Halliwell,et al.  Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. , 1991, Biochemical pharmacology.

[30]  P. Schnohr,et al.  Mortality associated with moderate intakes of wine, beer, or spirits , 1995, BMJ.

[31]  N. Das Studies on flavonoid metabolism. Absorption and metabolism of (+)-catechin in man. , 1971, Biochemical pharmacology.

[32]  E. Feskens,et al.  Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.

[33]  Y Hanasaki,et al.  The correlation between active oxygens scavenging and antioxidative effects of flavonoids. , 1994, Free radical biology & medicine.

[34]  A. Nègre-Salvayre,et al.  Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. , 1992, Free radical biology & medicine.

[35]  U. Takahama Inhibition of lipoxygenase-dependent lipid peroxidation by quercetin: Mechanism of antioxidative function , 1985 .

[36]  E. Parks,et al.  Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine , 1993, The Lancet.

[37]  R. Cohen,et al.  Change in alcohol consumption and risk of death from all causes and from ischaemic heart disease. , 1991, BMJ.

[38]  S. Renaud,et al.  Wine, alcohol, platelets, and the French paradox for coronary heart disease , 1992, The Lancet.

[39]  A. Ferro-Luzzi,et al.  Effect of Ethanol on Red Wine Tannin−Protein (BSA) Interactions , 1997 .

[40]  K. Ingold,et al.  Quantitative measurement of the total, peroxyl radical‐trapping antioxidant capability of human blood plasma by controlled peroxidation , 1985, FEBS letters.

[41]  S. Brown,et al.  The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid. , 1992, Biochemical pharmacology.

[42]  T. Takeo,et al.  Absorption of (-)-epigallocatechin gallate into the circulation system of rats. , 1995, Bioscience, biotechnology, and biochemistry.